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Objective: To study the inhibition effect of siRNA on the expression of Wisp-1 gene in
Hca-F of mouse hepatocellular carcinoma cells strain and also its effect on the prolifer-
ation, migration and adhesion of hepatocellular carcinoma cells.
Methods: Three expression vectors of siRNA were constructed. Lipo2000 was
employed to transfect Hca-F cells and Western blot was used to detect the inhibition
effect of siRNA on the expression of Wisp-1 gene. Afterward, CCK8 was adopted to
detect the effect ofWisp-1 siRNA on the proliferation of Hca-F cells; Annexin V-FITC/PI
double staining ﬂow cytometry was used to detect the effect of Wisp-1 siRNA on the
apoptosis of Hca-F cells; Transwell was used to detect the effect of Wisp-1 siRNA on the
migration of Hca-F cells. The in vitro cell adhesion kit was used to detect of Wisp-1
siRNA on the change in the components of extracellular matrix to which Hca-F cells
adhered. Western blot was used to detect the activation of protein kinase B (AKT)/
glycogen synthase kinase-3b pathway and the expression of downstream target protein
p53 and matrix metalloproteinases-2.
Results: The siRNA showed interference effect on the expression of Wisp-1 gene.
Compared with the control group, after being transfected to cells, Wisp-1 siRNA could
signiﬁcantly inhibit the proliferation, migration and adhesion of Hca-F cells and also
promote the cell apoptosis, which was related to the down-regulated phosphorylation of
AKT and glycogen synthase kinase-3b and the expression of p53 and matrix
metalloproteinases-2 (P < 0.05).
Conclusions: The inhibition ofWisp-1 expression can reduce the proliferation, migration
and adhesion of mouse hepatocellular carcinoma cells, which is related to the AKT/
glycogen synthase kinase-3b pathway.Wisp-1 gene may be the potential target to cure the
hepatocellular carcinoma.1. Introduction
The primary hepatocellular carcinoma is one of most com-
mon cancers in the clinical practice. A research reported that [1]there were about 750 000 new diagnosed patients with the
hepatocellular carcinoma every year in the world and about
700 000 patients who died of the hepatocellular carcinoma,
where 50% occurred in China. The most common histologicgxia Medical University, Yinchuan, China.
, China.
25).
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hepatocellular carcinoma, accounting for 70%–80% of the
total. Most of hepatocellular carcinomas were the chronic
infection caused by the hepatitis B virus and hepatitis C virus
[2]. In recent years, with the advance in the techniques of
molecular biology, there had been the great progress in the
treatment of hepatocellular carcinoma; however, because of
the high recurrence rate and metastasis rate, the overall
prognosis for the hepatocellular carcinoma was still poor [3].
The biological characteristics of tumor cells are the most
important factors to affect the prognosis and the recurrence
and metastasis of tumor is the centralized reﬂection of
malignant tumor [4–6]. Therefore, there will be of theoretical
and practical signiﬁcance to study the issues related to the
proliferation, migration and adhesion of hepatocellular
carcinoma.
Wisp-1 is the member of cysteine rich 61/connective tissue
growth factor/nephroblastoma overexpressed gene family.
Wisp-1 plays a critical role in the proliferation, adhesion and
metastasis of cells, as well as the extracellular matrix accu-
mulation and mitosis [7]. According to recent researches, it is
indicated that the expression of Wisp-1 protein was related
to the onset, development, metastasis, inﬁltration and prog-
nosis of many malignant tumors. Besides, the distribution and
biological function of Wisp-1 was different in different tumors
[8]. It is reported that the expression of Wisp-1 gene in the
tumor cells of melanoma was negatively related to the
inﬁltration and metastasis of malignant tumor cells [9]. Wisp-
1 showed the high expression in the colon cancer and esoph-
ageal cancer [10,11]. Presently, there has been no research on
the effect of Wisp-1 in the hepatocellular carcinoma. To
explore the effect and mechanism of Wisp-1 in the hepato-
cellular carcinoma and seek the new target for the treatment of
hepatocellular carcinoma, in this study, mouse hepatocellular
carcinoma cells (Hca-F) were chosen as the subjects, while
RNA interference was adopted to observe the change in the
proliferation, migration and adhesion of Hca-F cells after the
silencing of Wisp-1 gene, in order to explain the effect of
Wisp-1 on the biological behavior of hepatocellular carcinoma
cells.2. Materials and methods
2.1. Materials and reagents
The mouse Hca-F were stored in this laboratory; RPMI 1640
and fetal bovine serum were purchased from HyClone,
Lipo2000 from Invitrogen, BCA kit and cell adhesion analytical
reagent, Annexin V-FITC/PI double staining ﬂow cytometry kit
from Beyotime Biotechnology, CCK8 kit from Dojindo,
Transwell cell plate from Corning, enzyme-labeled instrument
from Bio-Rad; anti-human Wisp-1 antibody and anti-humanTable 1
siRNA sequence of Wisp-1 gene.




Negative control (siRNA-NC) UUCTCCGAACGUGCGAPDH antibody from Abcam; rabbit anti p53, matrix metal-
loproteinases (MMP)-2, protein kinase B (AKT), p-AKT,
glycogen synthase kinase-3b (GSK3b) and p-GSK3b antibodies
from Cell Signaling Technology; horseradish peroxidase labeled
secondary antibody from Beijing Zhongshan Jinqiao Biotech-
nology; ECL Chemiluminescent Substrate Reagent Kit from
Life Technologies-WP20005; PVDF (polyvinylidene ﬂuoride)
ﬁlm from Millpore. The optical microscope is Olympus BX53;
CO2 incubator is Thermo Scientiﬁc Series 8000.
2.2. Methods
2.2.1. Design of siRNA sequence
The human Wisp-1 gene sequence was obtained from Gen-
eBank. According to the design principle of siRNA, the siRNA
target Designers (Ambion) was used to design 3 siRNAs tar-
geting the speciﬁc Wisp-1. The related sequence and negative
control were shown in Table 1. Each sequence was synthesized
by Shanghai Biochemical Engineering Co., Ltd.
2.2.2. Transfection and screening of siRNA
On the day before the transfection, mouse hepatocellular
carcinoma cells that were in the phase of logarithmic growth
were seeded on 6-well plate according to the cell density of
6 × 104 cells/well. When the cell conﬂuency reached to about
70%–80%, the Opti-MEM I that contained 0.5% fetal bovine
serum was mixed with Lipo2000 and siRNA. The mixture of
Lipo2000 and siRNA was added in cells. It was incubated in the
incubator at 37 C and with 5% CO2 for 48 h. The number of
transfected cells was observed under the ﬂuorescence micro-
scopy. Meanwhile, RT-PCR and Western Blot were employed to
detect the protein expression ofWisp-1, in order to determine the
best interference effect.
2.2.3. Detection of effect of Wisp-1 siRNA on cell
proliferation
The cell density of mouse hepatocellular carcinoma cells in
the phase of logarithmic digestion was adjusted to 1 × 104 cells/
mL and they were added in 96-well plate by 100 mL/well. Cells
were divided into three groups, namely WisP-1 siRNA trans-
fection group, control group (without treatment) and siRNA-NC
transfection group. Each group had 5 repeated wells and cells
were incubated in the incubator at 37 C and with 5% CO2. At
24 h, 28 h and 72 h of in vitro culture, each well was added with
10 mL CCK-8 to be cultured in the incubator for another 1 h. The
enzyme-labeled instrument was employed to detect the optical
density of samples in each group at 450 nm.
2.2.4. Detection of cell apoptosis by Annexin V-FITC/PI
double staining ﬂow cytometry
According to the above procedure, cells were seeded on





Figure 1. Fluorescence photograph of Wisp-1 siRNA-transfected
Lipo2000 of mouse hepatocellular carcinoma cells.
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instruction manual of Annexin V-FITC/propidium iodide (PI)
cell apoptosis detection kit, cells were digested with 0.25%
trypsin (without EDTA), washed with PBS, centrifuged at
2 000 rpm for 5 min and then collected. A total of 500 mL
binding buffer was added to suspend the cells and then it was
mixed with 5 mL Annexin V-FITC and 5 mL PI. It was reacted in
a dark place and at the room temperature for 5–15 min and then
measured by the ﬂow cytometry within 1 h.
2.2.5. Detection of effect of Wisp-1 siRNA on cell
migration
Cells were divided into three groups, namely WisP-1
siRNA transfection group, control group and siRNA-NC
transfection group. The cell density was adjusted to
3 × 105 cells/mL and then the starvation culture was performed
on cells in the incubator for 24 h. The Transwell upper
chamber was added by 100 mL starvation cultured cells, while
the lower chamber was added by 500 mL culture medium that
contained 10% fetal bovine serum and 10 mg/mL ﬁbronectin.
After being cultured in the incubator at 37 C and with 5%
CO2 for 12 h, Transwell chamber was taken out. The residual
culture medium and non-migrated cells were removed by the
cotton swab carefully. Cells were dried at the room tempera-
ture for half an hour. Then the chamber was placed in the
solution with 0.1% crystal violet for the staining and then it
was washed with PBS several times. The number of migrated
hepatocellular carcinoma cells in 10 visual ﬁelds was counted
under the inverted microscopy and the mean values were
collected for the statistical analysis.
2.2.6. Effect of Wisp-1 siRNA-transfected cells on the
adhesion of components of extracellular matrix
The cell adhesion was employed to analyze the components
of each extracellular matrix in the kit. The culture medium that
contained 0.5% fetal bovine serum was used to prepare the
suspension cells. The cell density was adjusted to 1 × 106 cells/
mL. 150 mL cell suspension was added in each well of cell
adhesion plate. It was incubated for 1 h and then the supernatant
was sucked from each well. It was washed with PBS several
times. A total of 200 mL cell staining buffer was added in each
well and it was incubated at the room temperature for 10 min.
The cell staining buffer was then removed. It was washed with
ddH2O one time and then be sucked and dried. A total of 200 mL
extraction solution was added in each well. It was incubated at
the shaker for 10 min. A total of 100 mL solution was sucked
from each well to 96-well plate. The enzyme-labeled instrument
was used to measure OD value at 560 nm.
2.2.7. Detection of expression of transfected Wisp-1
protein and other related proteins by Western Blot
At 48 h after the transfection, cells in each group were
washed with PBS twice. After being digested with pancreatin,
the supernatant was removed. The precipitated cells were lysed
with RIPA lysis buffer. Then the protease inhibitor cocktail was
added for the blowing and mixing. After being put on the ice for
30–40 min, cells were lysed using the ultrasound. The probe-
type ultrasound was used to produce the short impact with the
appropriate frequency on the ice. The lysis mixture wascentrifuged at 4 C and 13 000 rpm/min for 20 min. The su-
pernatant was transferred to the new centrifuge tube. BCA kit
was employed to detect the protein concentration. SDS-PAGE
electrophoresis was performed on 20 mg total protein samples.
The gel was soaked in the transfer buffer for 10 min of equi-
librium. It was installed with the transfer ‘sandwich’, 100 V and
45–60 min. After the transfer, PVDF ﬁlm was washed with TBS
for 10–15 min. The ﬁlm was placed in TBS/T blocking buffer
containing 5% (w/v) skimmed milk powder and shaken at the
room temperature for 1 h. Then the primary antibody with the
appropriate degree of dilution was added [diluted with TBST
containing 1% (w/v) skimmed milk powder]. It was incubated at
the room temperature for 2 h and then the ﬁlm was washed with
TBST for 3 times and 5–10 min each time. The ﬁlm was
incubated with the secondary antibody (1:10 000, horseradish
peroxidase-labeled) that was diluted with TBST containing
0.05% (w/v) skimmed milk powder. It was incubated at the
room temperature for 1 h and then the ﬁlm was washed with
TBST for 3 times and 5–10 min each time. It was exposed and
then photographed to save the experimental results. Quantity
one v4.62 was used to measure the gray value of molecular
band.
2.3. Statistical analysis
Results were expressed by mean ± SD. Three repeats were
performed on the data of each group at least. The t test was
employed to detect the signiﬁcant difference, where P < 0.05
referred to the statistically signiﬁcant difference. The experi-
mental data was processed using SPSS 17.0.3. Results
3.1. Screening of siRNA interference fragment
Results of Western blot showed that the expression of Wisp-
1 protein in cells of siRNA-2 groups was signiﬁcantly lower
Figure 2. Expression of Wisp-1 protein.
A; RT-PCR; B: Western Blot.
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control and normal control, which indicated that the interfer-
ence effect of siRNA-2 was best. It was chosen as the inter-
ference fragment for the further experiments, as shown in
Figures 1 and 2.
3.2. CCK-8 cell proliferation
The optical density of each group after CCK8 detection was
shown in Table 2. According to the statistical treatment, there
was no signiﬁcant difference at 24 h, 48 h and 72 h between the
control group and siRNA-NC transfection group (P > 0.05), but
the optical density of Wisp-1 siRNA transfection group was
signiﬁcantly lower than ones of control group and siRNA-NC
transfection group (P < 0.05).
3.3. Cell apoptosis
The apoptosis rate of Wisp-1 siRNA transfection group was
signiﬁcantly higher than ones of control group and siRNA-NC
transfection group (P < 0.05), but there was no signiﬁcant dif-
ference between the control group and siRNA-NC transfection
group (P > 0.05), which indicated that the apoptosis rate of
mouse hepatocellular carcinoma cells after the silencing ofWisp-
1 gene was increased, as shown in Figure 3.
3.4. Transwell cell migration
The number of migrated cells in Wisp-1 siRNA transfection
group was signiﬁcantly lower than ones in the control group and
siRNA-NC transfection group (P < 0.05), but there was no
signiﬁcant difference between the control group and siRNA-NCTable 2
CCK-8 results of hepatocellular carcinoma cells at different time points (me
Group
24 h
Control group 0.166 3 ± 0.011 7*
siRNA-NC transfection group 0.167 6 ± 0.008 2*
Wisp-1 siRNA transfection group 0.132 3 ± 0.006 1
Note: * Compared with Wisp-1 siRNA transfection group, P < 0.05.transfection group (P > 0.05), which indicated that the migration
capacity of mouse hepatocellular carcinoma cells after the
silencing of Wisp-1 gene was signiﬁcantly reduced, as shown in
Table 3 and Figure 4.
3.5. Cell adhesion
Compared with the siRNA-NC transfection group and con-
trol one, the adhesion capacity of collagen I and fribrictin in
Wisp-1 siRNA transfection group was signiﬁcantly reduced
(P < 0.05), but there was no signiﬁcant difference in the adhe-
sion of other components. There was no signiﬁcant difference in
the cell adhesion between siRNA-NC transfection group and
control one, as shown in Table 4.
3.6. Expression of p53 and MMP-2
Compared with the siRNA-NC transfection group and
control group, the expression of p53 and MMP-2 was signiﬁ-
cantly inhibited inWisp-1 siRNA transfection group (P < 0.05).
There was no change in the expression of p53 and MMP-2 in
siRNA-NC transfection group and control group, as shown in
Figure 5.
3.7. Activation of AKT/GSK3b pathway
Compared with the siRNA-NC transfection group and con-
trol group, the phosphorylation of AKT and GSK3b was
signiﬁcantly inhibited in the Wisp-1 siRNA transfection group
(P < 0.05) and without any effect on its expression. AKT/
GSK3b was not activated in the siRNA-NC transfection group
and control group, as shown in Figure 6.an ± SD).
Optical density
48 h 72 h
0.210 0 ± 0.012 4* 0.391 3 ± 0.013 5v
0.202 5 ± 0.012 3* 0.459 9 ± 0.014 5*
0.146 0 ± 0.009 6 0.247 3 ± 0.011 6
Figure 3. Cell apoptosis.
*: Compared with Wisp-1 siRNA transfection group, P < 0.05.
Table 3
Number of migrated cells (n).
Group Repeated well 1 Repeated well 2 Repeated well 3 Average (mean ± SD)
Control group 215.3 208.9 214.7 213.0 ± 23.5*
siRNA-NC transfection group 207.4 210.5 212.2 210.0 ± 22.7*
Wisp-1 siRNA transfection group 145.7 140.6 129.8 138.7 ± 20.6
Note: * Compared with Wisp-1 siRNA transfection group, P < 0.05.
Figure 4. In vitro migration capacity of mouse hepatocellular carcinoma cells after down-regulated expression of Wisp-1 gene.
Table 4
Effect of Wisp-1 gene silencing on adhesion capacity of mouse hepatocellular carcinoma cells (mean ± SD).
Group Fribrinogen Ln Collagen I Collagen V Fribrictin
Control group 0.95 ± 0.12 0.85 ± 0.15 1.25 ± 0.20* 0.91 ± 0.25 1.48 ± 0.27*
siRNA-NC transfection group 0.88 ± 0.10 0.79 ± 0.08 1.19 ± 0.17* 0.89 ± 0.20 1.46 ± 0.25*
Wisp-1 siRNA transfection group 0.75 ± 0.09 0.70 ± 0.05 0.87 ± 0.11 0.77 ± 0.18 1.01 ± 0.23
Note: * Compared with Wisp-1 siRNA transfection group, P < 0.05.
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Figure 5. Effect of Wisp-1 gene silencing on expression of p53 and MMP-
2 in mouse hepatocellular carcinoma cells.
* Compared with Wisp-1 siRNA transfection group, P < 0.05.
Figure 6. Effect of Wisp-1 gene silencing on activation of AKT/GSK3b
pathway of mouse hepatocellular carcinoma cells.
* Compared with Wisp-1 siRNA transfection group, P < 0.05.
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More and more researches have shown that Wisp-1 is widely
expressed in many human tissues and organs. Because of its
biological functions to mediate the cell migration, promote the
cell proliferation and extracellular matrix accumulation and
stimulate the cell adhesion, it has been highly emphasized and
focused in the ﬁeld of biology at present [12]. The research
showed that the coding Wisp-1 gene is at 8q24.1-8q24.3 of
human chromosome. It is a secretory protein and peptide with
367 amino acids that is rich in cysteine, which can be
synthesized and secreted by vascular smooth muscle cells,vascular endothelial cells and ﬁbroblasts [13,14]. There was the
great difference in the expression of Wisp-1 gene in different
tissues, without the tissue speciﬁcity. The expression of Wisp-
1 could promote the pulmonary ﬁbrosis, be involved in the
development and repairing of bones and myocardial infarction,
and also promote the cancer progression [15–19].
In recent years, it is reported that relying on the interaction
with the extracellular matrix, Wisp-1 could regulate the onset,
development, metastasis and inﬁltration of malignant tumors.
Besides, the expression of Wisp-1 was closely related to the
prognosis and recurrence of tumors [20–22]. However, the
distribution and biological function of Wisp-1 was different in
different tumor tissues, which could negatively or positively
regulate the onset and development of tumors. Pennica et al. [23]
reported that, according to RT-PCR analysis, the expression of
Wisp-1 was signiﬁcantly increased in most colon cancer cells,
about 8 times more than the normal one. The mRNA in about
84% colon cancer tissues was increased by 2–15 times higher
than the related neighboring tissues. Based on the autocrine or
paracrine, Wisp-1 could stimulate the abnormal proliferation of
mammary epithelial cells and then cause the formation of breast
cancer. Besides, its protein expression was signiﬁcantly related
to the size of breast cancer, metastasis and course of lymph
nodes [24]; however, the expression of Wisp-1 in the lung cancer
tissue was signiﬁcantly lower than the one in the neighboring
normal lung tissue and the metastasis rate for the lung tumor
with the high expression of Wisp-1 was signiﬁcantly lower than
the one for the tumor with the low expression of Wisp-1 [25].
There has been no speciﬁc research on the function of Wisp-1
in the hepatocellular carcinoma tissue. This study was to
explore the role of Wisp-1 in mouse hepatocellular carcinoma
cells. The siRNA was employed to inhibit the expression of
Wisp-1 gene, while Western Blot was used to detect the
expression of Wisp-1 in mouse Hca-F stains that was transfected
with Wisp-1 siRNA-2 and results showed that the expression
was signiﬁcantly reduced. Afterward, according to the experi-
ments of cell proliferation, cell migration and cell adhesion, it is
to study the effect of inhibition of Wisp-1 expression on the
proliferation, migration and adhesion of cells. Results showed
that after the inhibition of Wisp-1 expression, the proliferation,
migration and adhesion of cells in Wisp-1 siRNA group was
signiﬁcantly lower than ones in the control group and siRNA-
NC group (P < 0.05). It is indicated that Wisp-1 could pro-
mote the proliferation, migration and adhesion of hepatocellular
carcinoma cells. The extracellular matrix and extracellular at-
tachments played a key role in the Wisp-1-induced tumor. It is
recognized that the adhesion molecule is the only known re-
ceptor of Wisp-1. Wisp-1 may cause the downstream reaction
through the adhesion molecule pathway and thus result in the
tumor. The proliferation, migration and adhesion are the basic
characteristics of biological behavior of tumor cells and also the
key cause for the metastasis and recurrence of malignant tumors.
The speciﬁc mechanism of Wisp-1 in the tumors has not
been clear. Wnt-1 and b-catenin can activate the Wisp-1 to
affect the transcriptional activity of Wisp-1; while Wisp-1 can
induce the phosphorylation of AKT to cause the phosphory-
lation of GSK3b and reduce the activity of GSK3b to inhibit
the cell apoptosis as the result of DNA injury [26,27]. Wisp-1
could regulate the activity of AKT, increase the expression
of surviving and inhibit the release of Bax and cytochrome C
[28]. Colston et al. [29] reported the function of Wisp-1/AKT
signal in the cardiac hypertrophy and indicated that Wisp-1
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involved in many basic cell processes of proliferation,
apoptosis, migration and invasion. AKT can cause the loss of
cell adhesion, change of morphology and disappear of polarity,
which thus reduce the cell adhesion and enhance the move-
ment. The abnormal activation of AKT in the hepatocellular
carcinoma tissue might be closely related to the prognosis of
patients [30]. The activated AKT could rely on the
phosphorylation to inhibit the expression of downstream
target proteins such as GSK-3b, p53 and MMP 2 and thus
regulate the proliferation, apoptosis and invasion of cells
[31,32]. GSK-3b is a key factor to regulate the cell apoptosis
and the important target protein in the downstream pathway
of PI3K/AKT, which was involved in the growth,
development and proliferation of cells [33,34]. By down-
regulating the phosphorylation of GSK-3b, it could signiﬁ-
cantly inhibit the proliferation of hepatocellular carcinoma cells
[35]. Wisp-1 could also inhibit p53 to regulate the cell apoptosis
and thus promote the tumor formation [36]. Wisp-1 could
include the expression and secretion of MMP-2 in human
chondrosarcoma cells and thus the interference against the
expression of MMP-2 could signiﬁcantly inhibit the Wisp-1-
induced cell migration [20]. The knockdown of mouse MMP-
2 might affect the secretion of MMPs, which was realized
through PI3K/Akt pathway [37]. The high expression of MMP-
2 and p53 was positively correlated to the size of hepatocellular
carcinoma and metastasis of lymph node. In hepatocellular
carcinoma cells, it could down-regulate the expression of p53
and MMP-2 through PI3K/AKT pathway and thus inhibit the
cell growth and invasion [38]. In this study, Western blot was
employed to detect the activation of AKT/GSK-3b and the
expression of p53 and MMP-2 in cells of each group. Re-
sults showed that the interference against the expression of
Wisp-1 in hepatocellular carcinoma cells could inactivate the
AKT/GSK-3b pathway and reduce the expression of p53 and
MMP-2 (P < 0.05). It can be seen that taking Wisp-1 as the
treatment target can improve the prognosis of malignant tumors
such as the hepatocellular carcinoma. However, as this study
was performed based on the in vitro experiment, it still requires
the further in vivo experiment for the validation.
In conclusion, through the direct expression in the tumor
cells, Wisp-1 can affect the proliferation, migration and invasion
of tumors, which may be related to the AKT/GSK-3b pathway.
It is found that the silencing of Wisp-1 gene in the primary
hepatocellular carcinoma can reduce the proliferation, migration
and adhesion of cells. Therefore, it will be necessary to study
Wisp-1 as the prognosis evaluation factor of malignant tumor
and choose it as the treatment target of tumors.
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